Poor regulation of the alternative pathway of complement by FH is also associated with Alzheimer’s disease [11], where changes in the sugar chain composition of the amyloid-β plaques associated with the disease [12] are believed to result in inadequate FH binding. The gene discussed is FH; the disease is Alzheimer disease.